Valid Insight is proud to be exhibiting at the World Evidence, Pricing and Access (EPA) Congress on 3–4 March at the RAI Convention Centre in Amsterdam.
As a Diamond Sponsor at Booth 100, we’ll be joining colleagues from across Europe for two days of discussion and collaboration across market access, pricing, evidence and HEOR.
Our team attending: Gerdi Strydom, Stephen Hall, Bas van Dijk, Inês Rodrigues de Oliveira and Emma Robson.
Presentation: Stephen Hall (Director) will be presenting “Access by design: embedding access into core development decisions” on 3 March at 10:40am as part of the keynote programme.
The World EPA Congress remains Europe’s largest event focused on market access, pricing and evidence, bringing together more than 1,500 attendees from pharma, biotech and payer/HTA organisations. This year’s agenda also expands with:
• A dedicated HEOR track, strengthening the academic and analytical depth of the programme
• A new poster area, supporting broader scientific exchange and evidence dialogue
• Continued focus on market access, pricing, rare diseases, reimbursement models, affordability and payer expectations
Across the two days, the congress provides a valuable platform to connect with decision‑makers and exchange perspectives on evolving topics across market access, pricing and evidence.
We look forward to welcoming delegates to our booth and contributing to the discussions shaping the future of patient access.
If you’d like to arrange a meeting with the team during the congress, please contact us at
discover@bioscriptgroup.com.